The developers said that trials to validate the technique had been carried out at a high-security that prototype kits should be available in Ebola-hit countries by the end of October for a clinical trial.
The technique, the developers said, reacts to the presence of the virus in a tiny sample which could be a drop of blood, plasma or urine.
The agency said: “Current tests, which are based on genetic detection of the virus, are highly sensitive but need special equipment, take between two and a quarter and two and a half hours and can only be carried out in a lab”
Scientists at the CEA started working on the diagnostic tool in August, when the epidemic worsened in Guinea, Liberia and Sierra Leone worsened. It was learnt that the development is part of the Ebola research funded in part by the French defence ministry as part of its anti-bioterrorism programme.
0 comments:
Post a Comment
Thanks for your interest in our site we will get back to you.